IL1B and Alzheimer disease: On a similar note, a single LPS injection was found to induce a trained phenotype of murine microglia; this in turn, promoted the neuropathology in a model of Alzheimer’s disease, increasing both amyloid-β levels and the plaque load, and augmented IL-1β levels after brain ischaemia (71).